Literature DB >> 15056492

Influence of neopterin on generation of reactive species by myeloperoxidase in human neutrophils.

Julia A Razumovitch1, Dietmar Fuchs, Galina N Semenkova, Sergei N Cherenkevich.   

Abstract

Increased neopterin concentrations in human serum indicate activation of cell-mediated immune response. Earlier we have shown that neopterin enhanced generation of singlet oxygen, hydroxyl radical and nitric oxide in human peripheral blood neutrophils by NADPH-independent pathways. To further investigate a participation of neopterin in reactive species production by neutrophils, we studied its influence on myeloperoxidase (MPO) activity. MPO was isolated from human peripheral blood neutrophils from healthy donors. Generation of reactive species by MPO/H(2)O(2) in Earl's solution (pH=7.2) at 37 degrees C was investigated by monitoring of chemiluminescence using luminol as light emitter. In the MPO/H(2)O(2) system, neopterin increased singlet oxygen in a concentration-dependent manner, but it decreased formation of other oxidizing species. Comparing several oxygen scavengers, formation of reactive species was totally blocked by sodium azide (NaN(3)), both in the presence and in the absence of neopterin. Superoxide dismutase (SOD) and d-mannitol insignificantly decreased chemiluminescence of this reaction, but diazabicyclo[2.2.2]octane (DABCO) strongly inhibited it. We conclude that the effects of neopterin on neutrophils' MPO are directed to increase singlet oxygen and to decrease other reactive species via inhibition of MPO and/or scavenging of reactive species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056492     DOI: 10.1016/j.bbagen.2004.02.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.

Authors:  S P Gieseg; E M Crone; E A Flavall; Z Amit
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

2.  Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis.

Authors:  Angela Horvath; Marija Durdevic; Bettina Leber; Katharina di Vora; Florian Rainer; Elisabeth Krones; Philipp Douschan; Walter Spindelboeck; Franziska Durchschein; Gernot Zollner; Rudolf E Stauber; Peter Fickert; Philipp Stiegler; Vanessa Stadlbauer
Journal:  Nutrients       Date:  2020-06-23       Impact factor: 5.717

3.  Clinical comparative study assessing the effect of ivabradine on neopterin and NT-Pro BNP against standard treatment in chronic heart failure patients.

Authors:  Gaidaa M Dogheim; Ibtsam Khairat; Gamal A Omran; Sahar M El-Haggar; Ahmed M El Amrawy; Rehab H Werida
Journal:  Eur J Clin Pharmacol       Date:  2022-03-03       Impact factor: 3.064

4.  Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis.

Authors:  A Horvath; B Leber; B Schmerboeck; M Tawdrous; G Zettel; A Hartl; T Madl; S Stryeck; D Fuchs; S Lemesch; P Douschan; E Krones; W Spindelboeck; F Durchschein; F Rainer; G Zollner; R E Stauber; P Fickert; P Stiegler; V Stadlbauer
Journal:  Aliment Pharmacol Ther       Date:  2016-09-04       Impact factor: 8.171

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.